However, medication alone is not enough
That is why its important to discuss any pre-existing conditions or allergies with your healthcare provider before getting the therapy
Common: appetite changes, fatigue, yawning Many users report eating less, feeling sleepy, or yawning soon after a dose
This is a drug that is bypassing our bodys natural functions
Animal studies support this idea, showing semaglutide altered dopamine activity specifically during the reward moment rather than during anticipation (3 Trusted Source GLP-1 Receptor Agonist Semaglutide Reduces Appetite While Increasing Dopamine Reward Signaling Go to source) (4 Trusted Source Risk of Depression with GLP-1 Receptor Agonist Use in Overweight or Obese Adults with Type 2 Diabetes Go to source)
Obesity is a known risk factor for breast cancer, so could some women reduce their odds of this common cancer by taking weight-loss drugs such as Wegovy and Zepbound